Clinical Trials Browser

No longer available × INDUSTRY × Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Clear all

NCT04518644 2023-04-28

Nilotinib, for Patients With CML-CP or CML-AP

No longer available

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT00302016 2011-08-26

Expanded Access Program of AMN107 in Imatinib-resistant or Intolerant Adult Patients With Chronic Myeloid Leukemia

No longer available

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive